Experts are seeing a rise of 15% in this multibagger stock in a month. should you buy

Highlighting the fundamentals that could fuel Max Healthcare’s stock price rally; HDFC Securities’ research report says, “Max’s Q3 proforma EBITDA roughly in line with Despite a seasonally weak quarter, 3.6 billion led by an all-time high ARPOB and decent volume on the back of continued momentum in the core business. With short and long term growth drivers (improvement in international trade, salary or mix, and expansion plans), we expect Max’s EBITDA to grow at a CAGR of around 15 per cent in FY22-FY28e.

The brokerage report said that the hospital business of Max Healthcare Institute is showing an encouraging trend. The company is operating at pre-pandemic levels with non-Covid beds, which account for about 99 per cent of the total occupied beds (as against 60 per cent clean in Q1).

Highlighting the chart pattern of Max Healthcare shares; Anuj Gupta, Vice President, IIFL Securities said, “For the past few days it has been trading between from 340 390 levels. The stock is trading in a narrow range with a positive outlook. One can buy the stock at approx. 360 each level for one month goal 425 per share level. However, the stop loss below must be maintained 340 Taking this positional call.”

Shares of Max Healthcare are one of the multibagger stocks in 2021. In the past year, it has increased from approx. from 185 375, appreciating almost 100 percent in this period. Its current market capitalization is 36,340 crore and its all-time high on NSE 458.05 each level on NSE. its 52-week low 180.60 per share level.

Disclaimer: The views and recommendations given above are those of individual analysts or broking companies and not of Mint.